{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T07:10:11Z","timestamp":1773645011801,"version":"3.50.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autonomous home-based transcranial direct current stimulation (HB-tDCS) is a scalable non-pharmacological intervention for chronic pain, but evidence under fully autonomous use remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify factors associated with adherence to fully autonomous HB-tDCS; to characterize the incidence, severity, and timing of adverse events under active and sham stimulation; and to examine if patient and clinical factors, including adverse events and clinical response, are associated with variability in adherence and safety outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Secondary pooled analysis of three double blind, sham-controlled randomized clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects<\/jats:title>\n                    <jats:p>A total of 234 women with fibromyalgia diagnosed according to the 2016 American College of Rheumatology criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants received a standardized autonomous HB-tDCS protocol (\u226520 sessions). The primary outcomes were adherence and safety. We examined associations with adherence and adverse events using generalized linear mixed-effects models, adjusted for demographic, clinical, and psychosocial factors. We also explored whether the burden of adverse events explained the link between treatment allocation and adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall adherence was 82.6% (95% CI, 81.6\u201383.6). Adherence rates were similar for the active (84.7%, 95% CI, 83.3\u201386.0) and sham groups (80.5%, 95% CI, 78.9\u201382.1). Older age (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u2009\u22120.024 sessions\/year; 95% CI, \u22120.040 to \u22120.008) and greater central sensitization (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u2009\u22120.025 per point; 95% CI, \u22120.040 to \u22120.010) were associated with lower adherence. Higher depressive symptom severity was linked to higher adherence (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.041 per point; 95% CI, 0.040\u20130.060). Most participants reported no adverse events (67.0%, 95% CI, 61.0\u201373.0), with no group differences (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.04,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.83). Reported events were mostly mild and brief. Active stimulation led to more frequent tingling and erythema. Higher education (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.078; 95% CI, 0.023\u20130.130) and depressive symptoms (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.037; 95% CI, 0.020\u20130.050) were associated with more adverse event reports. Greater functional impairment was linked to fewer reported events (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u2009\u22120.003; 95% CI, \u22120.040 to \u22120.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Autonomous home-based transcranial direct current stimulation was feasible, safe, and highly adhered to in fibromyalgia, with adherence and safety influenced by clinical and psychosocial factors, supporting scalable implementation in chronic pain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpain.2026.1773425","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T06:37:40Z","timestamp":1773643060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of adherence and safety in fully autonomous home-based transcranial direct current stimulation for fibromyalgia"],"prefix":"10.3389","volume":"7","author":[{"given":"Wolnei","family":"Caumo","sequence":"first","affiliation":[{"name":"Post-Graduate Program in Medical Sciences, School of Medicine, Universidade Federal do Rio Grande do Sul (UFRGS)","place":["Porto Alegre, Brazil"]},{"name":"Laboratory of Pain and Neuromodulation, Hospital de Cl\u00ednicas de Porto Alegre (HCPA)","place":["Porto Alegre, Brazil"]},{"name":"Pain and Palliative Care Service, Hospital de Cl\u00ednicas de Porto Alegre (HCPA) and Department of Surgery, School of Medicine, Universidade Federal do Rio Grande do Sul (UFRGS)","place":["Porto Alegre, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Bohrer","family":"Flores","sequence":"additional","affiliation":[{"name":"Post-Graduate Program in Medical Sciences, School of Medicine, Universidade Federal do Rio Grande do Sul (UFRGS)","place":["Porto Alegre, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela Souza","family":"Fontoura","sequence":"additional","affiliation":[{"name":"Laboratory of Pain and Neuromodulation, Hospital de Cl\u00ednicas de Porto Alegre (HCPA)","place":["Porto Alegre, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziele Borges","family":"Bueno","sequence":"additional","affiliation":[{"name":"Post-Graduate Program in Medical Sciences, School of Medicine, Universidade Federal do Rio Grande do Sul (UFRGS)","place":["Porto Alegre, Brazil"]},{"name":"Laboratory of Pain and Neuromodulation, Hospital de Cl\u00ednicas de Porto Alegre (HCPA)","place":["Porto Alegre, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Robeto","family":"Stefani Sanches","sequence":"additional","affiliation":[{"name":"Laboratory of Biomedical Engineering, Hospital de Cl\u00ednicas de Porto Alegre (HCPA)","place":["Porto Alegre, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Danton","family":"Pereira Silva","sequence":"additional","affiliation":[{"name":"Laboratory of Biomedical Engineering, Hospital de Cl\u00ednicas de Porto Alegre (HCPA)","place":["Porto Alegre, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraci L. S.","family":"Torres","sequence":"additional","affiliation":[{"name":"Post-Graduate Program in Medical Sciences, School of Medicine, Universidade Federal do Rio Grande do Sul (UFRGS)","place":["Porto Alegre, Brazil"]},{"name":"Laboratory of Pharmacology of Pain and Neuromodulation, Preclinical Investigations, Experimental Research Center, Hospital de Cl\u00ednicas de Porto Alegre (HCPA)","place":["Porto Alegre, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Fregni","sequence":"additional","affiliation":[{"name":"Laboratory of Neuromodulation and Center for Clinical Research Learning, Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed, and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e003904","DOI":"10.1136\/rmdopen-2023-003904","article-title":"Health inequities and societal costs for patients with fibromyalgia and their spouses: a Danish cohort study","volume":"10","author":"Amris","year":"2024","journal-title":"RMD Open"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/biomedicines12061266","article-title":"Management of fibromyalgia: an update","volume":"12","author":"Jones","year":"2024","journal-title":"Biomedicines"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2212939","DOI":"10.1001\/jamanetworkopen.2022.12939","article-title":"Comparison of amitriptyline and US food and drug administration\u2013approved treatments for fibromyalgia: a systematic review and network meta-analysis","volume":"5","author":"Farag","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2252037","DOI":"10.1080\/24740527.2023.2252037","article-title":"Pain medications used by persons living with fibromyalgia: a comparison between the profile of a Quebec sample and clinical practice guidelines","volume":"7","author":"De Clifford-Faug\u00e8re","year":"2023","journal-title":"Can J Pain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/528952","article-title":"Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines","volume":"2013","author":"Fitzcharles","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/annrheumdis-2022-eular.468","article-title":"OP0195 Prevalence of survey-based criteria for fibromyalgia and impact on hospital burden: a 7 years follow up study from an outpatient clinic","volume":"81","author":"Lage-Hansen","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/pme.12168","article-title":"Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the reflections study","volume":"14","author":"Robinson","year":"2013","journal-title":"Pain Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e14729","DOI":"10.1111\/ijcp.14729","article-title":"Utilisation of healthcare services and drug consumption in fibromyalgia: a cross-sectional analysis of the clalit health service database","volume":"75","author":"Gendelman","year":"2021","journal-title":"Int J Clin Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3899\/jrheum.170098","article-title":"Adherence and persistence with drug therapy among fibromyalgia patients: data from a large health maintenance organization","volume":"44","author":"Ben-Ami Shor","year":"2017","journal-title":"J Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1533-2500.2010.00431.x","article-title":"Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine","volume":"11","author":"Zhao","year":"2011","journal-title":"Pain Pract"},{"key":"B12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/rheumatology\/keh141","article-title":"Medication non-adherence in women with fibromyalgia","volume":"43","author":"Sewitch","year":"2004","journal-title":"Rheumatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/papr.12743","article-title":"Risk for medication nonadherence among medicaid enrollees with fibromyalgia: development of a validated risk prediction tool","volume":"19","author":"Desai","year":"2019","journal-title":"Pain Pract"},{"key":"B14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/00223891.2018.1464457","article-title":"A new measure of life satisfaction: the riverside life satisfaction scale","volume":"101","author":"Margolis","year":"2019","journal-title":"J Pers Assess"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e3072","DOI":"10.1002\/brb3.3072","article-title":"Assessment of clinical outcomes in patients with fibromyalgia: analysis from the UK medical Cannabis registry","volume":"13","author":"Wang","year":"2023","journal-title":"Brain Behav"},{"key":"B16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1469-7793.2000.t01-1-00633.x","article-title":"Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation","volume":"527","author":"Nitsche","year":"2000","journal-title":"J Physiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/ijnp\/pyaa051","article-title":"Evidence-based guidelines and secondary meta-analysis for the use of transcranial direct current stimulation in neurological and psychiatric disorders","volume":"24","author":"Fregni","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/RNN-2007-00375","article-title":"Repeated sessions of noninvasive brain DC stimulation is associated with motor function improvement in stroke patients","volume":"25","author":"Boggio","year":"2007","journal-title":"Restor Neurol Neurosci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.brs.2019.06.003","article-title":"Effects of 6-month at-home transcranial direct current stimulation on cognition and cerebral glucose metabolism in Alzheimer\u2019s disease","volume":"12","author":"Im","year":"2019","journal-title":"Brain Stimul"},{"key":"B20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.brs.2018.12.975","article-title":"Effects of single-session versus multi-session non-invasive brain stimulation on craving and consumption in individuals with drug addiction, eating disorders or obesity: a meta-analysis","volume":"12","author":"Song","year":"2019","journal-title":"Brain Stimul"},{"key":"B21","doi-asserted-by":"publisher","first-page":"57614","DOI":"10.3791\/57614","article-title":"Home-based transcranial direct current stimulation device development: an updated protocol used at home in healthy subjects and fibromyalgia patients","author":"Carvalho","year":"2018","journal-title":"J Vis Exp"},{"key":"B22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12984-019-0529-5","article-title":"Strategies to implement and monitor in-home transcranial electrical stimulation in neurological and psychiatric patient populations: a systematic review","volume":"16","author":"Sandran","year":"2019","journal-title":"J Neuroeng Rehabil"},{"key":"B23","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jpainsymman.2009.09.023","article-title":"Anodal transcranial direct current stimulation of the motor cortex ameliorates chronic pain and reduces short intracortical inhibition","volume":"39","author":"Antal","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"B24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12984-019-0514-z","article-title":"Long term at-home treatment with transcranial direct current stimulation (tDCS) improves symptoms of cerebellar ataxia: a case report","volume":"16","author":"Pilloni","year":"2019","journal-title":"J Neuroeng Rehabil"},{"key":"B25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clinph.2022.08.018","article-title":"Digitalized transcranial electrical stimulation: a consensus statement","volume":"143","author":"Brunoni","year":"2022","journal-title":"Clin Neurophysiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jpain.2019.06.013","article-title":"Large treatment effect with extended home-based transcranial direct current stimulation over dorsolateral prefrontal Cortex in fibromyalgia: a proof of concept sham-randomized clinical study","volume":"21","author":"Brietzke","year":"2020","journal-title":"J Pain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"992742","DOI":"10.3389\/fnhum.2022.992742","article-title":"The effect of home-based transcranial direct current stimulation in cognitive performance in fibromyalgia: a randomized, double-blind sham-controlled trial","volume":"16","author":"Serrano","year":"2022","journal-title":"Front Hum Neurosci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e2514262","DOI":"10.1001\/jamanetworkopen.2025.14262","article-title":"Home-Based transcranial direct current stimulation vs placebo for fibromyalgia: a randomized clinical trial","volume":"8","author":"Caumo","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jpain.2021.11.002","article-title":"Impact of bifrontal home-based transcranial direct current stimulation in pain catastrophizing and disability due to pain in fibromyalgia: a randomized, double-blind sham-controlled study","volume":"23","author":"Caumo","year":"2022","journal-title":"J Pain"},{"key":"B30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jpain.2023.09.001","article-title":"Efficacy of home-based transcranial direct current stimulation over the primary motor cortex and dorsolateral prefrontal cortex in the disability due to pain in fibromyalgia: a factorial sham-randomized clinical study","volume":"25","author":"Caumo","year":"2024","journal-title":"J Pain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1212\/WNL.57.10.1899","article-title":"Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans","volume":"57","author":"Nitsche","year":"2001","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.clinph.2017.06.001","article-title":"Low intensity transcranial electric stimulation: safety, ethical, legal regulatory and application guidelines","volume":"128","author":"Antal","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/qshc.3.3.153","article-title":"Improving quality of health care: the role of pharmacists","volume":"3","author":"Barber","year":"1994","journal-title":"Qual Health Care"},{"key":"B34","article-title":"Common Terminology Criteria for Adverse Events (CTCAE), Version 4.031","year":"2010"},{"key":"B35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.brs.2011.10.001","article-title":"Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices","volume":"5","author":"Peterchev","year":"2012","journal-title":"Brain Stimul"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.clinph.2009.01.022","article-title":"Safety limits of cathodal transcranial direct current stimulation in rats","volume":"120","author":"Liebetanz","year":"2009","journal-title":"Clin Neurophysiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.brs.2016.06.004","article-title":"Safety of transcranial direct current stimulation: evidence-based update 2016","volume":"9","author":"Bikson","year":"2016","journal-title":"Brain Stimul"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clinph.2015.11.012","article-title":"A technical guide to tDCS, and related non-invasive brain stimulation tools","volume":"127","author":"Woods","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1526-4637.2012.01528.x","article-title":"Cross-cultural adaptation and validation of the profile of chronic pain: screen for a Brazilian population","volume":"14","author":"Caumo","year":"2013","journal-title":"Pain Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1590\/S0482-50042006000100006","article-title":"Validation of a Brazilian version of the fibromyalgia impact questionnaire (FIQ)","volume":"46","author":"Marques","year":"2006","journal-title":"Rev Bras Reumatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.2147\/JPR.S131479","article-title":"The central sensitization inventory validated and adapted for a Brazilian population: psychometric properties and its relationship with brain-derived neurotrophic factor","volume":"10","author":"Caumo","year":"2017","journal-title":"J Pain Res"},{"key":"B42","first-page":"453","article-title":"Validation of a Portuguese version of the beck depression inventory and the state-trait anxiety inventory in Brazilian subjects","volume":"29","author":"Gorenstein","year":"1996","journal-title":"Braz J Med Biol Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1111\/j.1526-4637.2012.01492.x","article-title":"Cross-cultural adaptation and validation of the Brazilian Portuguese version of the pain catastrophizing scale","volume":"13","author":"Sehn","year":"2012","journal-title":"Pain Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","year":"2011","journal-title":"Adm Policy Ment Health"},{"key":"B46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/ner.12583","article-title":"Remotely supervised transcranial direct current stimulation increases the benefit of at-home cognitive training in multiple sclerosis","volume":"21","author":"Charvet","year":"2018","journal-title":"Neuromodulation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"20552076241292677","DOI":"10.1177\/20552076241292677","article-title":"The effectiveness of home-based transcranial direct current stimulation on chronic pain: a systematic review and meta-analysis","volume":"10","author":"Antonioni","year":"2024","journal-title":"Digit Health"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","article-title":"Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis","volume":"26","author":"Grenard","year":"2011","journal-title":"J Gen Intern Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/YCO.0b013e328343803b","article-title":"Role of expectations in health","volume":"24","author":"Colloca","year":"2011","journal-title":"Curr Opin Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1186\/s13063-020-04591-w","article-title":"Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials","volume":"21","author":"Kirby","year":"2020","journal-title":"Trials"},{"key":"B51","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.brs.2022.04.014","article-title":"Tolerability and feasibility of at-home remotely supervised transcranial direct current stimulation (RS-tDCS): single-center evidence from 6,779 sessions","volume":"15","author":"Pilloni","year":"2022","journal-title":"Brain Stimul"},{"key":"B52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cnp.2016.12.003","article-title":"Adverse events of tDCS and tACS: a review","volume":"2","author":"Matsumoto","year":"2017","journal-title":"Clin Neurophysiol Pract"},{"key":"B53","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.brs.2017.11.004","article-title":"Focal tDCS with 4\u00d71 ring configuration is safe and well tolerated: analysis of 2000 sessions","volume":"11","author":"Nikolin","year":"2018","journal-title":"Brain Stimul"},{"key":"B54","volume-title":"Placebo Effects: Understanding the Mechanisms in Health and Disease","author":"Benedetti","year":"2014"},{"key":"B55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5935\/2595-0118.20190015","article-title":"Adherence to fibromyalgia treatment: challenges and impact on the quality of life","volume":"2","author":"de Oliveira J\u00fanior","year":"2019","journal-title":"Br J Pain"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2255070","DOI":"10.1080\/24740527.2023.2255070","article-title":"Adherence to clinical guidelines for fibromyalgia: help or hindrance?","volume":"7","author":"Fitzcharles","year":"2023","journal-title":"Can J Pain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.brs.2020.02.011","article-title":"Supervised transcranial direct current stimulation (tDCS) at home: a guide for safe and effective use","volume":"13","author":"Charvet","year":"2020","journal-title":"Brain Stimul"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2026.1773425\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T06:37:42Z","timestamp":1773643062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2026.1773425\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":57,"alternative-id":["10.3389\/fpain.2026.1773425"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2026.1773425","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"article-number":"1773425"}}